Lifemd Inc (LFMD) financials
Lifemd revenue and earnings by year
Lifemd's revenue was $194 million in the fiscal year to December 31, 2025, up 25.3% from the year before. Net income was $14.4 million, 7.4% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 49.4% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 194 | 155 | 153 | 119 | 93 | 37 | 12 | 8 | 4 | 5 |
| Revenue growth | 25.3% | 1.5% | 28.2% | 28.2% | 149.0% | 199.1% | 49.8% | 126.1% | -29.7% | — |
| Gross profit | 166 | 133 | 134 | 100 | 75 | 28 | 10 | 6 | 3 | 3 |
| Gross margin | 85.7% | 86.2% | 87.6% | 84.3% | 80.6% | 76.2% | 79.7% | 76.0% | 72.4% | 62.9% |
| Operating income | -8 | -20 | -14 | -49 | -54 | -58 | -3 | -2 | -1 | -1 |
| Operating margin | -4.0% | -13.2% | -9.5% | -40.8% | -58.5% | -155.0% | -23.2% | -24.7% | -33.4% | -22.4% |
| Net income | 14 | -21 | -21 | -46 | -61 | -59 | -3 | -1 | -1 | -1 |
| Net margin | 7.4% | -13.8% | -13.5% | -38.3% | -65.6% | -157.3% | -25.2% | -14.9% | -32.8% | -21.1% |
| Diluted EPS | $0.24 | -$0.65 | -$0.70 | -$1.57 | -$2.28 | -$4.12 | -$0.36 | — | — | -$0.15 |
| Free cash flow | -1 | 9 | 0 | -32 | -36 | -13 | 0 | -1 | -1 | -0 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LFMD in Markets.
See also: LFMD returns
No forecast, no recommendation. This page describes Lifemd Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.